European Access Academy
A multi-stakeholder initiative aiming to facilitate and support the development of a joint European value framework for the assessment of innovative health technologies
The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.
The
EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's HTA Stakeholder Network.
EAA News & Media Posts
July 1st & 2nd, 2025: DG Santé Events on EU HTA in Brussels
The EAA would like to commend Maya Matthews and DG Santé for organizing two exciting days on EU HTA in Brussels.
Six months into the process it was excellent timing to i) hold the 5th HTA Stakeholder Network meeting covering first reflections on joint work and an intense discussion on key performance indicators, and ii) to organize the international hybrid conference on EU HTA titled “Advent of a new era of collaboration”.
In this early phase of the regulation’s implementation challenges are apparent in many aspects: tight timelines; new communication pathways; identifying and involving the right patient and best clinician experts; balancing the principles of expertise and transparency when selecting the experts.
However, DG Santé is orchestrating this early phase with all efforts and full commitment and we are looking forward to further supporting the successful implementation of the EU HTA Regulation.
We look forward to continuing the discussions on EU HTA:
Save the Date of the EAA Fall Convention 2025
'EU HTA - Procedural Insights/ First Learnings'
in Paris on November 6/7
including a joint EAA/ EUCOPE Pre-Convention Meeting on the challenges of small & medium-sized enterprises on Nov 6th:
'Enabling SME to successfully approach the EU HTA Process'
Registrations will open in August,
watch this space for further information.
Topical Collection at the Journal of Market Access and Health Policy on EU HTA:
The European Access Academy (EAA) and the Market Access Society (MAS) are editing a Topical Collection at JMAHP focusing on EU HTA, with Jörg Ruof and Mondher Toumi as guest editors. The goal of Collection is to generate a comprehensive resource consolidating relevant information and diverse perspectives from various stakeholders and a range of focus topics regarding EU HTA.
Access the Collection HERE directly at the journal or find a list of all articles in this collection HERE.
THANK YOU for joining the
EAA Spring Convention 2025
'Approaching Performance Measurement for EU HTA'
Once more we had excellent, heated and very fruitful and constructive discusssions with our experts (including Maya Matthews, Niklas Hedberg, Rui Santos Ivo, Bruno Falissard, Ansgar Hebborn, Andrew Wilson, Josephine Mosset, Bernhard Wörmann, Michael Berntgen, Giovanna Scroccaro, Christian Dierks), the German Oganising Committee (Jürgen Wasem, Frank-Ulrich Fricke, Bernhard Wörmann) and all our virtual and on-site participants.
EU HTA for Medical Devices poses opportunities but also a range of challenges for the MD that are in scope for JCA. In the Adjunct Roundtable Meeting we discussed how to approach success measurement in this context with our experts including Frédérique Debroucker, Maya Matthews, Monica Otto, Valentina Strammiello, Adrian Griffin, Andrea Mantovani, Andreas Stange, Frank-Ulrich Fricke, Jürgen Wasem, Marco Marchetti, Rob Nelissen, Ruben Casado, Walter Van Dyck and Yves Verboven.
Thanks so much to all who contributed!
EAA News & Media Posts - Archive
June 23, 2025: EAA Presentations at API-CCS event in Paris
Download the slides that were presented by the EAA Secretariat:
November 25, 2024: Open Letter from the EAA Faculty to the HTACG and DG Santé on the EU HTA Methods Guidance Documents
November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC for Medical Devices
October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC
June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI
June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain
April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons
April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA
Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'
Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA
Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts
The EAA is an initiative hosted by Copenhagen University, Utrecht University, Vlerick Business School, Agència de Qualitat I Avaluació Sanitàries de Catalunya, Erasmus University, LUISS Business School and endorsed & funded by:
Springer Healthcare, Abbvie, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Roche, Sanofi , vfa, leem, EUCOPE and efpia.